By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE
Suite 100
Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026


SEARCH JOBS

Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers.

YEAR FOUNDED:

March 18, 1996

LEADERSHIP:

Founder: Alton Boynton

CEO: Hua Bai

CEO: Linda Powers

CTO: Marnix Bosch

CSO (Scientific): Alton Boynton

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Products

FOLLOW NORTHWEST BIOTHERAPEUTICS:





Key Statistics


Email:
Ownership: Public

Web Site: NW Bio
Employees:
Symbol: NWBO
 



Industry
Services


Collaborations

Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy





Company News
NW Bio (NWBO) Announces Phase II Clinical Trial Program Combining DCVax-L And Pembrolizumab (Keytruda) For Colorectal Cancer 11/17/2016 8:16:28 AM
NW Bio (NWBO) Announces Registered Direct Offering 10/21/2016 9:15:01 AM
NW Bio (NWBO) Presents Further DCVax-Direct Phase I Trial Information On Individual Patient Survival At NY Cancer Immunotherapy Conference 9/29/2016 10:26:35 AM
NW Bio (NWBO) Presents Updated Data From DCVax-Direct Phase I Trial At 5th Annual SMi Cancer Vaccines Conference In London 9/22/2016 6:58:33 AM
NASDAQ Accepts NW Bio (NWBO) Remediation Plan For Shares And Warrants Previously Issued To Cognate BioServices, Inc. 9/6/2016 9:53:34 AM
SEC Filing Reveals NW Bio (NWBO) May No Longer be Capable of Paying Its Operating Expenses 8/17/2016 6:17:56 AM
NW Bio (NWBO) Announces A Registered Direct Offering Of $3.7 Million With New Institutional Investors 7/5/2016 7:52:38 AM
NW Bio (NWBO) Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement 7/1/2016 6:30:54 AM
A Look into NW Bio (NWBO)'s Downfall: Bad Management or Short Sellers? 6/24/2016 7:01:08 AM
NW Bio (NWBO) Announces Scientific Advisory Board 6/13/2016 10:35:50 AM
12345678910...
//-->